Clinical Scorecard: Stress Testing Exposes Glaucoma Risk
At a Glance
| Category | Detail |
|---|---|
| Condition | Glaucoma progression and intraocular pressure (IOP) response to the water-drinking test (WDT) |
| Key Mechanisms | The WDT transiently raises IOP; a higher peak may reveal limited IOP homeostasis or pressure peaks not captured by routine office measurements. |
| Target Population | People with glaucoma, including those whose office IOP is within severity-specific targets |
| Care Setting | Glaucoma clinical assessment and longitudinal monitoring; the WDT is an exploratory adjunct to routine office tonometry. |
Key Highlights
- A prospective study followed 67 glaucoma eyes from 36 participants for an average of 2.2 years.
- Mean office IOP was 14.8 mmHg, while mean WDT peak IOP was 20.6 mmHg.
- Eyes with WDT peak IOP above 21 mmHg had faster visual field mean deviation loss and retinal nerve fiber layer thinning.
- Among 59 eyes with acceptable office IOP, 22 (37%) exceeded 21 mmHg during WDT and showed faster progression than eyes remaining below that threshold.
- Of 13 rapid progressors, 10 reached a WDT peak above 21 mmHg, compared with 3 classified as above target by routine office measurements.
Guideline-Based Recommendations
Diagnosis
- The study evaluated WDT peak IOP, rise from baseline, and within-session fluctuation alongside longitudinal visual field mean deviation and retinal nerve fiber layer thickness.
Management
- The authors describe WDT as a potential additional risk-stratification tool; the study does not establish a treatment protocol or escalation threshold.
Monitoring & Follow-up
- Progression was tracked using clustered perimetry and spectral-domain OCT.
- The article suggests WDT may help identify apparently controlled eyes for closer surveillance, but this use requires further confirmation.
Risks
- The study was exploratory, with a modest cohort, average follow-up of just over two years, and uncontrolled treatment changes.
- The findings require confirmation in larger multicenter populations.
Patient & Prescribing Data
The study included 36 participants with glaucoma, contributing 67 eyes.
Participants drank one liter of water within five minutes; IOP was measured before ingestion and at 15, 30, and 45 minutes. Treatment changes were not controlled.
Clinical Best Practices
- Interpret office IOP alongside longitudinal functional and structural measures when assessing glaucoma progression.
- The study authors propose interpreting WDT as a composite stress test of the eye’s ability to maintain IOP homeostasis under challenge.
- Do not treat the study’s 21 mmHg WDT peak threshold as a validated treatment target; the article reports an association with progression and calls for further confirmation.
Related Resources & Content
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
